New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
The proceeds from the QIP will be used primarily to accelerate the nationwide expansion of the COCO stores of Davaindia nationwide
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Post the sale, Patel family has become the single largest promoter shareholder in the company
Fund VI will focus on investments in industrials and healthcare businesses with proven technologies and solutions positioned to deliver high performance and value-add to their customers
Subscribe To Our Newsletter & Stay Updated
